- Valuation
- ₹9,452 Cr

About Anupam Rasayan India Limited
Data last updated:
Anupam Rasayan India Limited is a public limited company based in Surat, Gujarat, India. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 30 September 2003 and has been in existence for over 23 years.
Anupam Rasayan India is part of the Nifty 500 index. Its director Kiran C Patel is #641 among India's richest people (2026). Its director Anand Sureshbhai Desai and Family is #748 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN L24231GJ2003PLC042988. Its GSTIN is 24AAECA4575D1ZY (Gujarat). The company holds 2 GST registrations, all of them active. It is a listed company as per MCA records. Its shares are listed on BSE: 543275 and NSE: ANURAS.
The company has an authorised share capital of ₹125 Cr and a paid-up capital of ₹113.85 Cr. It is led by directors including Anand Sureshbhai Desai (Managing Director) and Mona Anandbhai Desai (Whole-Time Director).
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Surat, Gujarat.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹2,365.45 Cr, a growth of 64.6% compared to the previous year. For the same year it recorded a net profit of ₹170.95 Cr (net margin 7.2%) and EBITDA of ₹524.83 Cr (EBITDA margin 22.2%). The net worth stands at ₹3,301.84 Cr (up 15.8% YoY). Total assets are valued at ₹6,544.37 Cr (up 45.4% YoY).
The company has about 1,642 employees on its provident fund (EPFO) records. Its group structure includes 4 subsidiaries.
The company is associated with 1 brand: Anupam Rasayan. As per MCA filings, the company has open charges of ₹5,748.2 Cr and satisfied charges of ₹1,770.02 Cr on record. Court records list 37 cases involving the company, including 20 filed by the company and 17 filed against it. The company has 27 deals on record (13 secondary share transfers, 8 funding rounds, 3 market trades), with disclosed funding of ₹650.56 Cr; the latest was in September 2026. Its 9 peer companies in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 5 smaller; the largest is Aquapharm Chemicals Private Limited with revenue of ₹1,571.7 Cr. The company has 3 MSME Form 1 returns on record for the period ending Sep 2019, listing 186 overdue payments to 29 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website anupamrasayan.com.
Company details
CIN history
Anupam Rasayan India has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24231GJ2003PLC042988, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24231GJ2003PLC042988 | Current |
| U24231GJ2003PTC042988 | Previous |
| U24231GJ2003PLC042988 | Previous |
Recognitions & Rankings of Anupam Rasayan India
- #641 Kiran C Patel ₹5,000 Cr
- #748 Anand Sureshbhai Desai & Family ₹4,200 Cr
Contact details
Anupam Rasayan India Limited's registered office is in Surat, Gujarat. Its website is anupamrasayan.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address1101 To1107 11th Floor Icon Rio B/H, Icon Business Centre Dumas Road, Surat, Gujarat, India – 395007
- IndustryChemicals and Materials, Specialty Chemicals
To see the full contact details of Anupam Rasayan India Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Anupam Rasayan India operates one associated brand: Anupam Rasayan. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Speciality chemicals are manufactured by Anupam Rasayan in India. | anupamrasayan.com |
Business activity
The main business activity of Anupam Rasayan India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Anupam Rasayan India Limited, buy the company report.
Financials of Anupam Rasayan India Limited
FY 2025-26 filings availableAnupam Rasayan India Limited reported revenue of ₹2,365.45 Cr (up 64.6% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 2,365 | 1,437 | 1,475 | 1,602 | 1,074 | 811 | 529 |
| Revenue growth | +64.6% | -2.6% | -7.9% | +49.2% | +32.4% | +53.3% | - |
| EBITDA | 525 | 401 | 381 | 431 | 305 | 194 | 135 |
| EBITDA margin | +22.2% | +27.9% | +25.8% | +26.9% | +28.4% | +23.9% | +25.5% |
| Profit before tax | 254 | 198 | 242 | 308 | 222 | 100 | 71.66 |
| Net profit | 171 | 93.13 | 125 | 181 | 152 | 70.44 | 52.97 |
| Net profit margin | +7.2% | +6.5% | +8.5% | +11.3% | +14.2% | +8.7% | +10.0% |
| EPS (₹) | 14.94 | 8.49 | 11.71 | 16.83 | 15.18 | 7.04 | 10.64 |
| Balance sheet | |||||||
| Total assets | 6,544 | 4,501 | 4,001 | 3,331 | 2,563 | 1,997 | 1,445 |
| Net worth | 3,302 | 2,850 | 2,761 | 2,373 | 1,727 | 1,573 | 594 |
| Total debt | 1,867 | 1,373 | 1,069 | 822 | 836 | 423 | 819 |
| Cash & bank | 394 | 128 | 289 | 564 | 210 | 296 | 26.83 |
| Net working capital | 2,403 | 1,908 | 1,677 | 1,675 | 1,174 | 813 | 352 |
| Cash flow | |||||||
| Cash from operations | 334 | (30.13) | 59.03 | 292 | (171) | 1.46 | 94.94 |
| Cash from investing | (820) | (330) | (392) | (523) | (412) | (193) | (178) |
| Cash from financing | 621 | 223 | 395 | 371 | 384 | 416 | 102 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 655 | 636 | 512 | 731 | 486 | 500 | 390 | 294 |
| Revenue growth (YoY) | +34.8% | +27.1% | +31.4% | +148.8% | +91.1% | - | - | - |
| Other income | 12.57 | 3.37 | 2.10 | 7.79 | 4.91 | 5.54 | (3.55) | 1.93 |
| EBITDA | 162 | 137 | 127 | 136 | 124 | 144 | 124 | 80.42 |
| EBITDA margin | +24.8% | +21.6% | +24.9% | +18.6% | +25.6% | +28.9% | +31.9% | +27.4% |
| Depreciation | 56.06 | 42.68 | 34.47 | 32.07 | 30.68 | 30.66 | 29.30 | 21.68 |
| Interest | 49.19 | 41.91 | 35.16 | 35.98 | 35.67 | 31.22 | 31.96 | 26.66 |
| Profit before tax | 69.69 | 56.07 | 59.95 | 75.53 | 62.85 | 88.12 | 59.49 | 34.01 |
| Tax | 18.47 | 0.08 | (0.65) | 18.38 | 14.39 | 25.18 | 5.29 | 3.40 |
| Net profit | 51.22 | 55.99 | 60.60 | 57.15 | 48.46 | 62.94 | 54.20 | 30.61 |
| EPS (₹) | 3.39 | 3.75 | 4.31 | 3.93 | 3.10 | 4.06 | 2.57 | 1.51 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 1,676 | 896 | 1,129 | 1,284 | 1,074 | 811 | 529 |
| Revenue growth | +87.0% | -20.6% | -12.1% | +19.6% | +32.4% | +53.3% | - |
| EBITDA | 405 | 265 | 307 | 367 | 304 | 193 | 134 |
| EBITDA margin | +24.2% | +29.6% | +27.2% | +28.6% | +28.3% | +23.8% | +25.4% |
| Profit before tax | 171 | 80.95 | 174 | 242 | 220 | 99.44 | 71.37 |
| Net profit | 162 | 72.50 | 114 | 169 | 151 | 70.08 | 52.76 |
| Net profit margin | +9.7% | +8.1% | +10.1% | +13.1% | +14.1% | +8.6% | +10.0% |
| EPS (₹) | 14.18 | 6.61 | 10.68 | 15.68 | 15.04 | 7.00 | 10.60 |
| Balance sheet | |||||||
| Total assets | 4,843 | 4,172 | 3,803 | 3,181 | 2,561 | 1,995 | 1,444 |
| Net worth | 3,235 | 2,805 | 2,737 | 2,359 | 1,725 | 1,573 | 593 |
| Total debt | 1,574 | 1,323 | 1,067 | 822 | 836 | 423 | 818 |
| Cash & bank | 63.55 | 88.70 | 279 | 551 | 210 | 296 | 26.67 |
| Net working capital | 1,848 | 1,731 | 1,610 | 1,615 | 1,172 | 812 | 350 |
| Cash flow | |||||||
| Cash from operations | 274 | (64.82) | 21.77 | 244 | (171) | 0.89 | 94.75 |
| Cash from investing | (656) | (286) | (362) | (478) | (412) | (192) | (178) |
| Cash from financing | 356 | 192 | 398 | 376 | 384 | 416 | 102 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 329 | 371 | 401 | 588 | 316 | 331 | 212 | 191 |
| Revenue growth (YoY) | +4.2% | +12.1% | +89.3% | +208.4% | +92.6% | - | - | - |
| Other income | 6.08 | 2.49 | 4.95 | 7.70 | 4.83 | 5.32 | (2.89) | 3.86 |
| Total expenses | 219 | 270 | 301 | 479 | 221 | 225 | 140 | 139 |
| EBITDA | 109 | 101 | 101 | 109 | 94.25 | 106 | 72.16 | 52.12 |
| EBITDA margin | +33.3% | +27.2% | +25.1% | +18.6% | +29.9% | +31.9% | +34.0% | +27.3% |
| Depreciation | 31.71 | 31.42 | 29.30 | 27.64 | 26.44 | 26.57 | 25.79 | 19.78 |
| Interest | 42.09 | 37.37 | 33.59 | 34.75 | 33.72 | 29.13 | 30.50 | 25.35 |
| Profit before tax | 41.70 | 34.68 | 42.74 | 54.60 | 38.92 | 55.12 | 12.98 | 10.85 |
| Tax | 9.70 | (7.71) | (5.18) | 13.19 | 9.23 | 17.04 | (6.16) | (3.18) |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 655 | 636 | 512 | 731 | 486 | 500 | 390 | 294 |
| Revenue growth (YoY) | +34.8% | +27.1% | +31.4% | +148.8% | +91.1% | - | - | - |
| Other income | 12.57 | 3.37 | 2.10 | 7.79 | 4.91 | 5.54 | (3.55) | 1.93 |
| EBITDA | 162 | 137 | 127 | 136 | 124 | 144 | 124 | 80.42 |
| EBITDA margin | +24.8% | +21.6% | +24.9% | +18.6% | +25.6% | +28.9% | +31.9% | +27.4% |
| Depreciation | 56.06 | 42.68 | 34.47 | 32.07 | 30.68 | 30.66 | 29.30 | 21.68 |
| Interest | 49.19 | 41.91 | 35.16 | 35.98 | 35.67 | 31.22 | 31.96 | 26.66 |
| Profit before tax | 69.69 | 56.07 | 59.95 | 75.53 | 62.85 | 88.12 | 59.49 | 34.01 |
| Tax | 18.47 | 0.08 | (0.65) | 18.38 | 14.39 | 25.18 | 5.29 | 3.40 |
| Net profit | 51.22 | 55.99 | 60.60 | 57.15 | 48.46 | 62.94 | 54.20 | 30.61 |
| EPS (₹) | 3.39 | 3.75 | 4.31 | 3.93 | 3.10 | 4.06 | 2.57 | 1.51 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 2,365 | 1,437 | 1,475 | 1,602 | 1,074 | 811 | 529 |
| Revenue growth | +64.6% | -2.6% | -7.9% | +49.2% | +32.4% | +53.3% | - |
| Other income | 18.17 | 11.48 | 30.25 | 10.04 | 7.99 | 26.61 | 10.88 |
| Total expenses | 1,841 | 1,036 | 1,094 | 1,171 | 769 | 617 | 394 |
| Employee cost | 86.58 | 73.62 | 75.14 | 68.90 | 48.50 | 32.44 | 21.09 |
| EBITDA | 525 | 401 | 381 | 431 | 305 | 194 | 135 |
| EBITDA margin | +22.2% | +27.9% | +25.8% | +26.9% | +28.4% | +23.9% | +25.5% |
| Depreciation | 140 | 102 | 79.70 | 71.08 | 60.12 | 51.65 | 28.71 |
| Interest | 149 | 112 | 89.43 | 62.66 | 30.83 | 68.54 | 45.26 |
| Profit before tax | 254 | 198 | 242 | 308 | 222 | 100 | 71.66 |
| Tax | 32.20 | 37.88 | 74.34 | 90.82 | 69.68 | 29.71 | 18.47 |
| Net profit | 171 | 93.13 | 125 | 181 | 152 | 70.44 | 52.97 |
| Net profit margin | +7.2% | +6.5% | +8.5% | +11.3% | +14.2% | +8.7% | +10.0% |
| EPS (₹) | 14.94 | 8.49 | 11.71 | 16.83 | 15.18 | 7.04 | 10.64 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 114 | 110 | 110 | 107 | 100 | 99.92 | 78.13 |
| Reserves & surplus | 3,188 | 2,648 | 2,559 | 2,265 | 1,627 | 1,473 | 515 |
| Shareholders' funds (net worth) | 3,302 | 2,850 | 2,761 | 2,373 | 1,727 | 1,573 | 594 |
| Minority interest | 1,328 | 231 | 170 | 135 | 0.00 | 0.00 | 0.00 |
| Secured loans | 1,815 | 1,312 | 943 | 644 | 600 | 136 | 553 |
| Unsecured loans | 52.83 | 61.55 | 126 | 178 | 237 | 288 | 265 |
| Total debt | 1,867 | 1,373 | 1,069 | 822 | 836 | 423 | 819 |
| Total liabilities | 6,544 | 4,501 | 4,001 | 3,331 | 2,563 | 1,997 | 1,445 |
| Assets | |||||||
| Gross block | 4,914 | 2,778 | 1,994 | 1,830 | 1,432 | 1,287 | 1,098 |
| Net block | 3,713 | 2,185 | 1,501 | 1,417 | 1,202 | 1,115 | 977 |
| Capital work in progress | 114 | 216 | 609 | 120 | 43.70 | 43.22 | 101 |
| Investments | 18.52 | 8.56 | 66.62 | 67.04 | 149 | 0.02 | 0.40 |
| Inventories | 1,775 | 1,452 | 1,055 | 931 | 863 | 492 | 297 |
| Sundry debtors | 959 | 734 | 579 | 415 | 280 | 205 | 129 |
| Cash & bank balances | 394 | 128 | 289 | 564 | 210 | 296 | 26.83 |
| Loans & advances | 583 | 253 | 237 | 135 | 93.64 | 97.05 | 98.39 |
| Total current assets | 3,711 | 2,566 | 2,161 | 2,046 | 1,447 | 1,090 | 552 |
| Total current liabilities | 1,307 | 658 | 484 | 371 | 273 | 277 | 200 |
| Net working capital | 2,403 | 1,908 | 1,677 | 1,675 | 1,174 | 813 | 352 |
| Total assets | 6,544 | 4,501 | 4,001 | 3,331 | 2,563 | 1,997 | 1,445 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 243 | 250 | 188 | 47.75 | 241 | 17.02 | (1.60) |
| Net cash from operating activities | 334 | (30.13) | 59.03 | 292 | (171) | 1.46 | 94.94 |
| Net cash from investing activities | (820) | (330) | (392) | (523) | (412) | (193) | (178) |
| Net cash from financing activities | 621 | 223 | 395 | 371 | 384 | 416 | 102 |
| Net change in cash | 135 | (137) | 61.99 | 140 | (199) | 224 | 18.62 |
| Closing cash | 394 | 128 | 289 | 564 | 210 | 296 | 26.83 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +64.6% | -2.6% | -7.9% | +49.2% | +32.4% | +53.3% | - |
| EBITDA growth | +30.9% | +5.3% | -11.8% | +41.5% | +57.5% | +43.7% | - |
| PBT growth | +28.6% | -18.2% | -21.4% | +38.7% | +121.8% | +39.6% | +9.0% |
| Net income growth | +83.6% | -25.6% | -30.8% | +18.7% | +116.3% | +33.0% | - |
| Revenue CAGR (3Y) | +13.9% | +10.2% | +22.1% | +44.7% | +28.9% | - | - |
| EBITDA CAGR (3Y) | +6.8% | +9.6% | +25.3% | +47.4% | +48.5% | - | - |
| Profitability & leverage | |||||||
| Net income margin | +9.4% | +11.1% | +11.4% | +13.5% | +14.2% | +8.7% | +10.1% |
| Return on capital employed | +8.5% | +7.7% | +9.4% | +12.9% | +11.1% | +9.8% | +8.9% |
| Return on net worth | +7.2% | +5.7% | +6.5% | +10.6% | +9.2% | +6.6% | +10.2% |
| Debt / equity | 0.53 | 0.44 | 0.37 | 0.40 | 0.38 | 0.57 | 1.35 |
| Long-term debt / equity | 0.13 | 0.08 | 0.12 | 0.22 | 0.24 | 0.37 | 0.90 |
| Interest cover | 38.63 | 37.59 | 29.71 | 17.39 | 12.60 | 48.29 | 42.68 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 0.62 | 0.60 | 0.77 | 0.98 | 0.79 | 0.68 | 0.56 |
| Inventory turnover | 1.47 | 1.15 | 1.48 | 1.79 | 1.58 | 2.05 | 2.15 |
| Debtors turnover | 2.79 | 2.19 | 2.97 | 4.61 | 4.42 | 4.84 | 4.23 |
| EPS (₹) | 14.94 | 8.49 | 11.71 | 16.83 | 15.18 | 7.04 | 10.64 |
| Dividend per share (₹) | 1.50 | 0.75 | 1.25 | 2.50 | 1.00 | 0.50 | 0.00 |
| Book value per share (₹) | 290.02 | 250.87 | 243.07 | 220.78 | 172.26 | 157.46 | 113.08 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 329 | 371 | 401 | 588 | 316 | 331 | 212 | 191 |
| Revenue growth (YoY) | +4.2% | +12.1% | +89.3% | +208.4% | +92.6% | - | - | - |
| Other income | 6.08 | 2.49 | 4.95 | 7.70 | 4.83 | 5.32 | (2.89) | 3.86 |
| Total expenses | 219 | 270 | 301 | 479 | 221 | 225 | 140 | 139 |
| EBITDA | 109 | 101 | 101 | 109 | 94.25 | 106 | 72.16 | 52.12 |
| EBITDA margin | +33.3% | +27.2% | +25.1% | +18.6% | +29.9% | +31.9% | +34.0% | +27.3% |
| Depreciation | 31.71 | 31.42 | 29.30 | 27.64 | 26.44 | 26.57 | 25.79 | 19.78 |
| Interest | 42.09 | 37.37 | 33.59 | 34.75 | 33.72 | 29.13 | 30.50 | 25.35 |
| Profit before tax | 41.70 | 34.68 | 42.74 | 54.60 | 38.92 | 55.12 | 12.98 | 10.85 |
| Tax | 9.70 | (7.71) | (5.18) | 13.19 | 9.23 | 17.04 | (6.16) | (3.18) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 1,676 | 896 | 1,129 | 1,284 | 1,074 | 811 | 529 |
| Revenue growth | +87.0% | -20.6% | -12.1% | +19.6% | +32.4% | +53.3% | - |
| Other income | 19.96 | 13.35 | 25.91 | 2.19 | 7.34 | 26.61 | 10.88 |
| Total expenses | 1,270 | 631 | 822 | 917 | 770 | 618 | 394 |
| Employee cost | 45.08 | 49.85 | 54.48 | 54.47 | 48.50 | 32.44 | 21.09 |
| EBITDA | 405 | 265 | 307 | 367 | 304 | 193 | 134 |
| EBITDA margin | +24.2% | +29.6% | +27.2% | +28.6% | +28.3% | +23.8% | +25.4% |
| Depreciation | 115 | 90.77 | 71.87 | 65.56 | 60.12 | 51.65 | 28.71 |
| Interest | 139 | 107 | 87.40 | 61.86 | 30.83 | 68.54 | 45.26 |
| Profit before tax | 171 | 80.95 | 174 | 242 | 220 | 99.44 | 71.37 |
| Tax | 9.53 | 8.28 | 56.36 | 73.71 | 69.41 | 29.50 | 18.39 |
| Net profit | 162 | 72.50 | 114 | 169 | 151 | 70.08 | 52.76 |
| Net profit margin | +9.7% | +8.1% | +10.1% | +13.1% | +14.1% | +8.6% | +10.0% |
| EPS (₹) | 14.18 | 6.61 | 10.68 | 15.68 | 15.04 | 7.00 | 10.60 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 114 | 110 | 110 | 107 | 100 | 99.92 | 78.13 |
| Reserves & surplus | 3,121 | 2,603 | 2,534 | 2,252 | 1,624 | 1,473 | 515 |
| Shareholders' funds (net worth) | 3,235 | 2,805 | 2,737 | 2,359 | 1,725 | 1,573 | 593 |
| Secured loans | 1,523 | 1,262 | 941 | 644 | 600 | 136 | 553 |
| Unsecured loans | 50.74 | 61.55 | 126 | 178 | 237 | 287 | 265 |
| Total debt | 1,574 | 1,323 | 1,067 | 822 | 836 | 423 | 818 |
| Total liabilities | 4,843 | 4,172 | 3,803 | 3,181 | 2,561 | 1,995 | 1,444 |
| Assets | |||||||
| Gross block | 2,758 | 2,304 | 1,641 | 1,535 | 1,433 | 1,288 | 1,099 |
| Net block | 2,186 | 1,849 | 1,277 | 1,240 | 1,203 | 1,116 | 978 |
| Capital work in progress | 68.44 | 206 | 579 | 113 | 42.78 | 42.45 | 101 |
| Investments | 350 | 159 | 159 | 158 | 148 | 0.01 | 0.41 |
| Inventories | 1,398 | 1,355 | 991 | 880 | 863 | 491 | 297 |
| Sundry debtors | 920 | 652 | 545 | 373 | 280 | 205 | 129 |
| Cash & bank balances | 63.55 | 88.70 | 279 | 551 | 210 | 296 | 26.67 |
| Loans & advances | 434 | 238 | 230 | 126 | 90.32 | 95.38 | 96.67 |
| Total current assets | 2,816 | 2,333 | 2,045 | 1,930 | 1,443 | 1,088 | 550 |
| Total current liabilities | 968 | 602 | 435 | 315 | 271 | 276 | 200 |
| Net working capital | 1,848 | 1,731 | 1,610 | 1,615 | 1,172 | 812 | 350 |
| Total assets | 4,843 | 4,172 | 3,803 | 3,181 | 2,561 | 1,995 | 1,444 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 81.81 | 241 | 184 | 42.06 | 241 | 16.86 | (1.74) |
| Net cash from operating activities | 274 | (64.82) | 21.77 | 244 | (171) | 0.89 | 94.75 |
| Net cash from investing activities | (656) | (286) | (362) | (478) | (412) | (192) | (178) |
| Net cash from financing activities | 356 | 192 | 398 | 376 | 384 | 416 | 102 |
| Net change in cash | (25.64) | (160) | 57.74 | 142 | (199) | 224 | 18.60 |
| Closing cash | 63.55 | 88.70 | 279 | 551 | 210 | 296 | 26.67 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +87.0% | -20.6% | -12.1% | +19.6% | +32.4% | +53.3% | - |
| EBITDA growth | +52.8% | -13.6% | -16.5% | +21.0% | +57.4% | +43.6% | - |
| PBT growth | +111.1% | -53.4% | -28.3% | +10.0% | +121.4% | +39.3% | +8.6% |
| Net income growth | +123.2% | -36.2% | -32.6% | +11.6% | +115.4% | +32.8% | - |
| Revenue CAGR (3Y) | +9.3% | -5.9% | +11.7% | +34.4% | +28.9% | +33.3% | +22.4% |
| EBITDA CAGR (3Y) | +3.3% | -4.4% | +16.7% | +39.8% | +48.1% | +38.1% | +24.1% |
| Profitability & leverage | |||||||
| Net income margin | +9.6% | +8.1% | +10.4% | +13.1% | +14.0% | +8.6% | +10.0% |
| Return on capital employed | +6.9% | +4.7% | +7.5% | +10.6% | +11.0% | +9.8% | +8.9% |
| Return on net worth | +5.3% | +2.6% | +4.6% | +8.3% | +9.2% | +6.5% | +10.1% |
| Debt / equity | 0.48 | 0.43 | 0.37 | 0.41 | 0.38 | 0.57 | 1.35 |
| Long-term debt / equity | 0.10 | 0.08 | 0.12 | 0.22 | 0.24 | -0.85 | -18,817.06 |
| Interest cover | 48.02 | 61.24 | 37.17 | 20.49 | 12.65 | 48.48 | 42.80 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 0.66 | 0.45 | 0.71 | 0.87 | 0.79 | 0.68 | 0.56 |
| Inventory turnover | 1.22 | 0.76 | 1.21 | 1.47 | 1.59 | 2.06 | 2.15 |
| Debtors turnover | 2.13 | 1.50 | 2.46 | 3.93 | 4.42 | 4.84 | 4.23 |
| EPS (₹) | 14.18 | 6.61 | 10.68 | 15.68 | 15.04 | 7.00 | 10.60 |
| Dividend per share (₹) | 1.50 | 0.75 | 1.25 | 2.50 | 1.00 | 0.50 | 0.00 |
| Book value per share (₹) | 284.15 | 246.75 | 240.84 | 219.55 | 172.04 | 157.38 | 113.00 |
To see the full year-wise statements and ratios of Anupam Rasayan India Limited, buy the company report.
Board of directors of Anupam Rasayan India Limited
Anupam Rasayan India has 8 current directors and 21 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mona Anandbhai Desai Also directs: Rehash Industrial and Resins Chemicals Private Limited | Whole-Time Director | 30 Sep 2003 | 23 Years 1 Months | Current |
| Anand Sureshbhai Desai | Managing Director | 30 Sep 2003 | 23 Years 1 Months | Current |
| Kiran Chhotubhai Patel | Director | 09 Jan 2019 | 7 Years 9 Months | Current |
| Milind Madan Talathi | Director | 25 Sep 2025 | 1 Years 1 Months | Current |
| Anand Rajeshwarrao Chatorikar | Director | 03 Dec 2024 | 1 Years 10 Months | Current |
| Ketan Paragji Desai | Director | 09 Nov 2024 | 1 Years 11 Months | Current |
Peer comparison
Anupam Rasayan India Limited is compared with the 9 companies closest to it by revenue in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anupam Rasayan India Limitedthis company | ₹2,365.45 Cr (FY 2026) | ₹170.95 Cr | 7.2% | 64.6% | 1,642 | Surat, Gujarat, India |
| Aquapharm Chemicals Private Limited | ₹1,571.7 Cr (FY 2024) | -23.0% | Pune, Maharashtra, India | |||
| Kanoria Chemicals & Industries Ltd | ₹1,545.92 Cr (FY 2025) | 3.0% | Kolkata, West Bengal, India | |||
| Jesons Industries Limited | ₹1,536.53 Cr (FY 2025) | 3.0% | Mumbai, Maharashtra, India | |||
| Vishnu Chemicals Limited | ₹1,461.88 Cr (FY 2025) | 19.0% | Hyderabad, Telangana, India | |||
| Aquapharm Chemical Limited | ₹1,431.07 Cr (FY 2025) | 491.0% | Pune, Maharashtra, India | |||
| Balaji Amines Limited | ₹1,430.29 Cr (FY 2025) | -14.0% | Solapur, Maharashtra, India | |||
| Nocil Limited | ₹1,424.79 Cr (FY 2025) | -4.0% | Mumbai, Maharashtra, India | |||
| Archean Chemical Industries Limited | ₹1,373.41 Cr (FY 2024) | -7.0% | Chennai, Tamil Nadu, India | |||
| Novopor Advanced Science Private Limited | ₹1,314.03 Cr (FY 2025) | 66.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Anupam Rasayan India Limited, buy the company report.
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 59.10%, foreign institutional investors hold 7.70%, domestic institutional investors hold 0.40% and retail and other public shareholders hold 32.80%.
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 59.10% | 59.10% | 59.10% | 59.10% |
| Public | 40.90% | 40.90% | 40.90% | 40.90% |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Sep 2026 | 101400350 | Others | ₹120 Cr | Open | |
| 02 Sep 2026 | 101388209 | Others | ₹283.8 Cr | Open | |
| 30 Jun 2026 | 101330520 | Others | ₹150 Cr | Open | |
| 30 Jun 2026 | 101339070 | Others | ₹75 Cr | Open | |
| 29 May 2026 | 101312892 | Others | ₹50 Cr | Open |
To see the full charge records of Anupam Rasayan India Limited, buy the company report.
Total charge records: 58 View all charges
Deals & funding
Anupam Rasayan India Limited has 27 deals on record (13 secondary share transfers, 8 funding rounds, 3 market trades), with disclosed funding of ₹650.56 Cr; the latest was in September 2026.
Deals on record (5 of 27)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2024 | Market trade | ₹57.84 Cr | Buyer: Jainam Broking Limited , an individual Seller: Jainam Broking Limited , an individual |
| Dec 2023 | Funding round | ₹180 Cr | Investors: Rehash Industrial and Resins Chemicals Private Limited |
| May 2021 | Market trade | ₹129.45 Cr | Buyer: Plutus Wealth Management LLP |
| May 2010 | Secondary share transfer | Undisclosed | Buyer: Rehash Industrial and Resins Chemicals Private Limited , an individual Seller: 4 individuals |
| Aug 2006 | Funding round | ₹11.2 Lakh | Investors: Rehash Industrial and Resins Chemicals Private Limited |
To see the full deal history of Anupam Rasayan India Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Anupam Rasayan India Limited has 37 court cases on record: 20 filed by Anupam Rasayan India, 17 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 24 | 13 | 0 |
| High courts | 13 | 4 | 0 |
Cases on record (5 of 37)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Bharuch, Gujarat | Court case (SPCS) | Filed by the company against M.Mech Engineers Pvt. Ltd | Disposed |
| District court, Vadodara, Gujarat | Commercial matter | Filed by the company against M Mech Engineers Pvt. Ltd. | Disposed |
| District court, SURAT, Gujarat | Criminal complaint | Filed by the company against Alka Laboratories Pvt. Ltd. and 1 other | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Civil suit | Filed by the company against Container Corporation of India Ltd | Disposed |
| Bombay High Court | Court case (S) | Filed by the company against Container Corporation of India Ltd. | Disposed |
To see the full case history of Anupam Rasayan India Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Anupam Rasayan India Limited was last rated by Crisil on 29 Oct 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 29 Oct 2020 |
To see the full credit ratings and regulatory alerts of Anupam Rasayan India Limited, buy the company report.
MSME payment delays
Anupam Rasayan India Limited has 3 MSME Form 1 returns on record for the period ending Sep 2019, listing 186 overdue payments to 29 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 29)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Jobby Engineers Private Limited | |||
| an individual supplier | |||
| Fidicon Devices India | |||
| an individual supplier |
To see the full MSME payment records of Anupam Rasayan India Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Anupam Rasayan India has 4 subsidiary companies. This group structure data is as of FY 2025. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Tanfac Industries Limited | L24117TN1972PLC006271 | |
| Aril Fluorospecialit Y Private Limited | U20119GJ2023PTC142228 | |
| Jainam Intermediates Private Limited | U24304GJ2017PTC098269 | |
| Aril Transmodal Logistic Private Limited | U49231GJ2023PTC138896 |
To see the full group structure of Anupam Rasayan India Limited, buy the company report.
Employees & EPFO
Anupam Rasayan India Limited has a workforce of 1,642 employees on its EPFO records as of Oct 08, 2025, across 1 active EPFO establishment.
GST
Anupam Rasayan India has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAECA4575D1ZY | Gujarat | Active | 01 Jul 2017 |
| 27AAECA4575D1ZS | Maharashtra | Active | 15 Feb 2024 |
To see the full GST registrations and return filing status of Anupam Rasayan India Limited, buy the company report.
Recent activity
Anupam Rasayan India Limited has 44 board changes on record since 2003: 27 appointments and 17 cessations. The latest: Milind Madan Talathi was appointed as Director on 25 Sep 2025.
151 earlier events are in the company report.
News
Frequently asked questions
Anupam Rasayan India is an active public limited company based in Surat, Gujarat, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 30 September 2003 (23+ years old) and is registered under CIN L24231GJ2003PLC042988. Listed on BSE: 543275 and NSE: ANURAS.
Anupam Rasayan India reported revenue of ₹2,365.45 Cr for FY 2025-26 (up 64.6% YoY) based on consolidated financials.
Anupam Rasayan India has 8 current directors:
- Anand Sureshbhai Desai - Managing Director
- Mona Anandbhai Desai - Whole-Time Director
- Anuj Hemantbhai Thakar - Whole-Time Director
- Kiran Chhotubhai Patel - Director
- Milind Madan Talathi - Director
- Anand Rajeshwarrao Chatorikar - Director
- Ketan Paragji Desai - Director
- Madhuri Ajit Sawant - Director
The latest financial statements of Anupam Rasayan India on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 26 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Anupam Rasayan India is 24AAECA4575D1ZY, registered in Gujarat. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 27AAECA4575D1ZS (Maharashtra).
The CIN (Corporate Identification Number) of Anupam Rasayan India is L24231GJ2003PLC042988. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Anupam Rasayan India is a listed company as per MCA records. Its shares are listed on both BSE (code: 543275) and NSE (symbol: ANURAS).
Anupam Rasayan India has 37 court cases on record: 20 filed by the company and 17 filed against it. Most are in the district courts.
Anupam Rasayan India was incorporated on 30 September 2003, making it 23+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Anupam Rasayan India has 27 deals on record (13 secondary share transfers, 8 funding rounds, 3 market trades), with disclosed funding of ₹650.56 Cr; the latest was in September 2026.
The peers of Anupam Rasayan India by revenue are Aquapharm Chemicals Private Limited, Kanoria Chemicals & Industries Ltd, Jesons Industries Limited, Vishnu Chemicals Limited, Aquapharm Chemical Limited and 4 more, all in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Milind Madan Talathi was appointed as Director on 25 Sep 2025. Bikram Singh ceased to be Director on 27 Jun 2025. Anand Rajeshwarrao Chatorikar was appointed as Director on 03 Dec 2024. Anupam Rasayan India has 44 board changes on record in total.

